| Treatment of coronavirus disease 2019 (COVID-19) patients with convalescent plasma E Salazar, KK Perez, M Ashraf, J Chen, B Castillo, PA Christensen, ... The American journal of pathology 190 (8), 1680-1690, 2020 | 315 | 2020 |
| Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial CR Wolfe, KM Tomashek, TF Patterson, CA Gomez, VC Marconi, MK Jain, ... The lancet respiratory medicine 10 (9), 888-899, 2022 | 87 | 2022 |
| Treatment of COVID-19 patients with convalescent plasma in Houston, Texas E Salazar, KK Perez, M Ashraf, J Chen, B Castillo, PA Christensen, ... medRxiv, 2020.05. 08.20095471, 2020 | 43 | 2020 |
| Role of rapid diagnostics in diagnosis and management of patients with sepsis TA Eubank, SW Long, KK Perez The Journal of infectious diseases 222 (Supplement_2), S103-S109, 2020 | 36 | 2020 |
| Genetic Mechanisms of Vancomycin Resistance in Clostridioides difficile: A Systematic Review TA Eubank, AJ Gonzales-Luna, JG Hurdle, KW Garey Antibiotics 11 (2), 258, 2022 | 22 | 2022 |
| Successful treatment of invasive mucormycosis in orthotopic liver transplant population TA Eubank, CM Mobley, M Moaddab, MJ Hobeika, M O’Neal, WL Musick, ... Case Reports in Transplantation 2021, 2021 | 5 | 2021 |
| Surveillance of Clostridioides difficile Antimicrobial Resistance in the United States AJ Gonzales-Luna, C Dureja, TA Eubank, KW Garey, JG Hurdle Clinical Infectious Diseases 76 (11), 2038-2039, 2023 | 3 | 2023 |
| Significant publications on infectious diseases pharmacotherapy in 2020 TA Eubank, N Zaidan, FS Alnezary, C Moc, K Olson, A Zaki, ... Journal of Pharmacy Practice 36 (2), 394-406, 2023 | 2 | 2023 |
| Impact of hypoalbuminemia on ceftriaxone treatment failure in patients with Enterobacterales bacteremia: a propensity-matched, retrospective cohort study EL Steere, TA Eubank, MH Cooper, SB Greenlee, TC Drake Open Forum Infectious Diseases 10 (3), ofad102, 2023 | 2 | 2023 |
| Reduced Vancomycin Susceptibility in Clostridioides difficile is Associated with Lower Rates of Initial Cure and Sustained Clinical Response TA Eubank, C Dureja, KW Garey, JG Hurdle, AJ Gonzales-Luna Clinical Infectious Diseases, ciae087, 2024 | | 2024 |
| Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile E Bassères, TA Eubank, K Begum, MJ Alam, J Jo, TM Le, CK Lancaster, ... Antimicrobial Agents and Chemotherapy, e01621-23, 2024 | | 2024 |
| 2164. Resistome patterns associated with vancomycin non-susceptibility in clinical Clostridioides difficile isolates TA Eubank, AJ Gonzales-Luna, BM Hanson, T Treangen, A Earl, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1787, 2023 | | 2023 |
| 682. Novel rpoB mutations and trends in clinical Clostridioides difficile isolates with reduced fidaxomicin susceptibility AJ Gonzales-Luna, T Le, TA Eubank, ME Karim, M Jahangir Alam, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 744, 2023 | | 2023 |
| 674. Host and Pathogen Risk Factors for Fulminant Clostridioides difficile Infection HC Chua, TA Eubank, J Jo, KW Garey, AJ Gonzales-Luna Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 736, 2023 | | 2023 |
| Detectable Vancomycin Stool Concentrations in Hospitalized Patients with Diarrhea Given Intravenous Vancomycin TA Eubank, C Hu, AJ Gonzales-Luna, KW Garey Pharmacoepidemiology 2 (4), 283-288, 2023 | | 2023 |
| 1839. Impact of Hypoalbuminemia on Ceftriaxone Treatment Failure in Patients With Enterobacterales Bacteremia E Steere, T Eubank, S Greenlee, M Cooper, TC Drake Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 1468, 2022 | | 2022 |
| 380. A molecular epidemiological exploration of reduced vancomycin susceptibility in Clostridioides difficile TA Eubank, C Dureja, JG Hurdle, KW Garey, AJ Gonzales-Luna Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 458, 2022 | | 2022 |
| 401. Rigor and Reproducibility of Clostridioides difficile susceptibility testing C Lancaster, TA Eubank, AJ Gonzales-Luna, C Dureja, J Hurdle, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 479, 2022 | | 2022 |
| 338. Multicenter Evaluation of Superinfection Occurrence and Impact on Clinical Outcomes in Patients with COVID-19 TA Eubank, K Perez, WL Musick, KW Garey Open Forum Infectious Diseases 8 (Suppl 1), S273, 2021 | | 2021 |
| Treatment of COVID-19 Patients with Convalescent Plasma in Houston, Texas (preprint) E Salazar, KK Perez, M Ashraf, J Chen, B Castillo, PA Christensen, ... | | 2020 |
